
Supplements for SSRI-induced ED: what the evidence actually shows
SSRI-induced ED supplements reviewed against PubMed: saffron, L-citrulline, maca, plus yohimbine and ginkgo red flags. Evidence gaps noted.
Sexual Health
Guides for people comparing supplement options around SSRI-induced sexual side effects, erectile function support, and what the trials actually show. New here? Start with our nitric oxide pathway overview if you are comparing NO boosters to prescription ED drugs.
What belongs here: supplement evidence for antidepressant-induced sexual dysfunction, erectile-function support, and related safety context: what trials show, without overpromising.
What does not: replacing a psychiatry or urology visit, or “herbal Viagra” claims that ignore dose, population, and PDE5 evidence.
How to use this hub: if you are comparing nitric-oxide boosters to prescription ED drugs, start with the nitric oxide pathway overview; for SSRI-induced ED specifically, use the AISD evidence review.
Evidence tools
Trial presets, label checks, dose floors, and physician-reviewed interaction pairs. Browser-only, nothing stored.
All guides in this category

SSRI-induced ED supplements reviewed against PubMed: saffron, L-citrulline, maca, plus yohimbine and ginkgo red flags. Evidence gaps noted.

Korean red ginseng at 2.7 to 3 g a day for 8 to 12 weeks: six trials, mostly positive, effect modest. How that stacks up against Viagra before you buy.

2024 network meta-analysis plus 1.5 g/day RCT data on L-citrulline vs L-arginine for ED. What the systematic reviews actually found, and what they did not.

Erectile dysfunction after weight gain reviewed against PubMed: the mechanism, weight loss trials that restored function, GLP-1 data, and supplement evidence.

NO supplements for ED: modest evidence in mild vascular ED. Routes to citrulline, arginine, and ginseng guides. Stacking with PDE5 drugs or nitrates flagged.